Lack of association between MAGEL2 and schizophrenia and mood disorders in the Japanese population.
Several investigations have reported that abnormalities in circadian rhythms might be related with the pathophysiology of psychiatric disorders, since many psychiatric patients have insomnia and sleep-awake disturbance. A recent animal study reported that Magel2, which encodes a member of the MAGE/necdin family of proteins, might be associated in the pathophysiology of psychiatric disorders. Magel2 gene knockout mice showed altered concentrations of both dopamine and serotonin in several parts of the brain compared with controls. In addition, the authors of that study detected a bilateral reduction in cortical volume in distinct regions of the Magel2 gene knockout mice brain, including focused regions in the parieto-temporal lobe of the cerebral cortex, the amygdala, the hippocampus, and the nucleus accumbens. These mice were also found to have hypoactivity and abnormalities in circadian rhythms. From this evidence, we considered Magel2 gene (MAGEL2) to be a good candidate gene for the pathophysiology of schizophrenia and mood disorder, and we conducted a case-control study among Japanese (731 schizophrenia patients, 465 MDD patients, 156 BP patients and 758 controls) using three tagging SNPs in MAGEL2 (rs850815, rs8920 and rs4480754), selected using the HapMap database. We did not find any association between MAGEL2 and schizophrenia, BP or MDD in allele/genotype-wise analysis or haplotype-wise analysis. Our results suggest that MAGEL2 may not play a role in the pathophysiology of schizophrenia and mood disorders in the Japanese population. A replication study using larger samples may be required for conclusive results, since our sample size was small and our study analyzed only three SNPs in MAGEL2.
Fukuo
Yasuhisa
Y
Department of Pychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Kishi
Taro
T
Okochi
Tomo
T
Kitajima
Tsuyoshi
T
Tsunoka
Tomoko
T
Okumukura
Takenori
T
Kinoshita
Yoko
Y
Kawashima
Kunihiro
K
Yamanouchi
Yoshio
Y
Umene-Nakano
Wakako
W
Naitoh
Hiroshi
H
Inada
Toshiya
T
Yoshimura
Reiji
R
Nakamura
Jun
J
Ozaki
Norio
N
Iwata
Nakao
N
D000328:Adult; D000818:Animals; D044466:Asian People / Q000235:genetics / Q000523:psychology; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D008297:Male; D051379:Mice; D008875:Middle Aged; D019964:Mood Disorders / Q000235:genetics* / Q000503:physiopathology; D020641:Polymorphism, Single Nucleotide; D011506:Proteins / Q000235:genetics*; D012559:Schizophrenia / Q000235:genetics* / Q000503:physiopathology; D055815:Young Adult; D047908:Intracellular Signaling Peptides and Proteins; D064267:Intrinsically Disordered Proteins
D011506:Proteins; C510822:MAGEL2 protein, human; D047908:Intracellular Signaling Peptides and Proteins; D064267:Intrinsically Disordered Proteins
Curr Psychiatry Rep. 2008 Dec;10(6):505-9
18980734
Eur Arch Psychiatry Clin Neurosci. 1998;248(3):157-60
9728735
Pharmacol Ther. 2007 May;114(2):222-32
17395264
Cell Physiol Biochem. 2007;20(6):687-702
17982252
Eur Arch Psychiatry Clin Neurosci. 2009 Aug;259(5):293-7
19224106
Psychol Med. 2008 Oct;38(10):1505-14
18177526
Neurobiol Dis. 2009 Jun;34(3):518-24
19344762
Psychiatry Res. 2006 Dec 1;148(2-3):75-92
17088049
Curr Opin Psychiatry. 2009 May;22(3):320-5
19293715
Neuropharmacology. 2010 Feb;58(2):452-6
19747927
Psychiatry Res. 2010 Apr 30;182(1):9-13
20227253
Nat Genet. 2007 Oct;39(10):1266-72
17893678
Am J Med Genet B Neuropsychiatr Genet. 2006 Apr 5;141B(3):234-41
16528748
Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 5;147B(7):1116-25
18361419
Biol Psychiatry. 2010 Feb 1;67(3):283-6
19880096
Eur J Hum Genet. 2009 May;17(5):582-90
19066619
Neuroimage. 2010 Feb 15;49(4):2966-76
19931399
J Hum Genet. 2009 Nov;54(11):629-33
19730445
J Intellect Disabil Res. 2007 Jan;51(Pt 1):32-42
17181601
Biol Psychiatry. 2006 Jun 15;59(12):1151-9
16566899
Genes Brain Behav. 2006 Mar;5(2):150-7
16507006
Neurosci Res. 2008 Dec;62(4):211-5
18804497
Eur Arch Psychiatry Clin Neurosci. 2005 Jun;255(3):159-66
15995899
Am J Psychiatry. 2008 May;165(5):610-6
18347002
Bipolar Disord. 2008 Feb;10(1):1-37
18199239
Neuromolecular Med. 2009;11(2):114-22
19544013
ScientificWorldJournal. 2007 Nov 02;7:194-202
17982593
Arch Gen Psychiatry. 1988 Aug;45(8):742-7
3395203
Eur Arch Psychiatry Clin Neurosci. 2007 Apr;257(3):173-82
17149537
Neuropsychopharmacology. 2010 May;35(6):1279-89
20072116
J Clin Psychiatry. 2008 May;69(5):749-58
18363423
Biol Psychiatry. 2008 Jun 15;63(12):1185-9
18367154
Neuromolecular Med. 2010 Sep;12(3):237-42
19937159
Neurobiol Dis. 2010 May;38(2):181-91
18840528
Psychiatry Res. 2010 Jan 30;181(1):64-70
19959342
Bipolar Disord. 2009 Nov;11(7):701-10
19839995
Cold Spring Harb Symp Quant Biol. 2007;72:637-44
18419323
Am J Med Genet B Neuropsychiatr Genet. 2009 Dec 5;150B(8):1085-99
19199291
Psychiatr Serv. 2001 Jan;52(1):51-5
11141528
Eur Arch Psychiatry Clin Neurosci. 2008 Jun;258 Suppl 2:97-106
18516521
Bioinformatics. 2005 Jan 15;21(2):263-5
15297300
Bioinformatics. 2003 Jan;19(1):149-50
12499305
Bipolar Disord. 2009 Mar;11(2):215-20
19267705
Am J Med Genet B Neuropsychiatr Genet. 2010 Jun 5;153B(4):960-6
20029941
Neuromolecular Med. 2009;11(2):53-7
19347611
Neuropsychobiology. 2009;59(4):234-8
19571598
Am J Hum Genet. 2008 Oct;83(4):445-56
18817904
Psychiatr Genet. 2009 Aug;19(4):217-8
19421079
Nature. 2008 Sep 11;455(7210):232-6
18668039
PLoS Genet. 2008 May 30;4(5):e1000040
18516223
Neurosci Res. 2009 Jun;64(2):231-4
19428704
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Aug 1;33(5):895-8
19386276
Pharmacogenomics. 2007 Sep;8(9):1097-100
17924823
Biol Psychiatry. 2009 Aug 15;66(4):349-59
19278672
Acta Psychiatr Scand Suppl. 2007;(434):41-9
17688462
Hum Mol Genet. 2007 Nov 15;16(22):2713-9
17728320
Genet Epidemiol. 2003 Sep;25(2):115-21
12916020